• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SENSEONICS INC. EVERSENSE TRANSMITTER; EVERSENSE CONTINUOUS GLUCOSE MONITORING SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SENSEONICS INC. EVERSENSE TRANSMITTER; EVERSENSE CONTINUOUS GLUCOSE MONITORING SYSTEM Back to Search Results
Model Number 102208-904
Device Problem Imprecision (1307)
Patient Problem Hyperglycemia (1905)
Event Date 07/26/2023
Event Type  Injury  
Manufacturer Narrative
This report is being submitted retrospectively as part of internal review.The initial investigation was performed on the user synced glucose data on data management system (dms), which is an eversense cloud platform.Based on the initial investigation analysis, the customer reported glucose values could not be confirmed because the data between (b)(6) 2023 10:23 pm and (b)(6) 7:09 pm was not synced.The initial investigation analysis revealed continuous gaps in glucose data and calibration past due alerts, suggesting that the transmitter was removed for long periods of time and the system was not used consistently.High levels of sensor variability were seen in brief times whenever the system was in use.To further investigate the sensor variability, a return material authorization (rma) was authorized for return of the sensor.However, the rma was never received.As a result, the no further investigation was possible and the root cause of the complaint could not be established.One potential root cause of the observed variability could be attributed to inconsistent system usage and not calibrating timely.
 
Event Description
Senseonics was made aware of an incident where the customer had a false hypoglycemia event on (b)(6) 2023 at 11 pm.The customer reported that sensor glucose (sg) went below the low alert threshold of 52 mg/dl triggering a low glucose alert.The sg value was 52 mg/dl where as the measured blood glucose (bg) value was 305 mg/dl.Since the measured bg value was very high, the customer injected insulin.The customer did not seek any medical treatment.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVERSENSE TRANSMITTER
Type of Device
EVERSENSE CONTINUOUS GLUCOSE MONITORING SYSTEM
Manufacturer (Section D)
SENSEONICS INC.
20451 seneca meadows pkwy
germantown MD 20876 7005
Manufacturer (Section G)
SENSEONICS INC.
20451 seneca meadows pkwy
germantown MD 20876 7005
Manufacturer Contact
vallikannu somasundaram
20451 seneca meadows pkwy
germantown, MD 20876-7005
MDR Report Key18117259
MDR Text Key327879904
Report Number3009862700-2023-00287
Device Sequence Number1
Product Code QHJ
UDI-Device Identifier00817491023384
UDI-Public817491023384
Combination Product (y/n)Y
Reporter Country CodeGM
PMA/PMN Number
P160048
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Other
Type of Report Initial
Report Date 11/12/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/12/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date08/05/2023
Device Model Number102208-904
Device Catalogue NumberFG-3500-04-001
Device Lot Number131057
Was Device Available for Evaluation? No
Date Manufacturer Received09/08/2023
Was Device Evaluated by Manufacturer? No
Date Device Manufactured08/05/2022
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-